Nia Haware and Marcia Pennant work jointly as Legacy Marketing Officers in our Development and Communications Office.
A team of scientists at The Institute of Cancer Research, London, has developed a repeatable three-dimensional (3D) imaging technique that could transform preclinical cancer studies. The researchers ...
Work with the Institute of Cancer Research and help people with cancer. Enquire about trusts and foundations today.
New research presents clear guidelines on how patient-reported outcomes (PROs) can be used more effectively in early-stage cancer drug trials, helping ensure that patient experiences meaningfully ...
The Institute of Cancer Research, London, welcomes the decision by the National Institute for Health and Care Excellence (NICE) to recommend the targeted drug talazoparib (trade name Talzenna), in ...
A blood test can predict how well patients with advanced breast cancer will respond to targeted therapies – before treatment begins, according to new research. A team from The Institute of Cancer ...
The Institute of Cancer Research, London has welcomed the announcement by NHS England that the lifesaving drug abiraterone has been approved for use on the NHS for men in England with prostate cancer ...
Tens of thousands of tumour samples which have been stored in the basement of a London hospital for more than 70 years could be the key to unlocking the mystery of why bowel cancer cases are rising in ...
Experts at The Institute of Cancer Research, London, have responded to the draft recommendation from the National Screening Committee (NSC) to implement a targeted prostate cancer screening programme ...
The Institute of Cancer Research, London, has received the highest national honour in UK further and higher education for its pioneering radiotherapy research. The Queen Elizabeth Prizes for Higher ...
Scientists have uncovered a protein that acts like a ‘suit of armour’ for cancer cells, shielding them from hostile environments and allowing one of the deadliest forms of skin cancer to spread ...
A new type of cancer treatment which is given via an injection under the skin has shown early signs of success in patients with advanced head and neck cancer. Results of the phase Ib/II Orig-AMI 4 ...